NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
54 hedge funds and large institutions have $2.79M invested in Navidea Biopharmaceuticals Inc. in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
54
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$11K | |
| 2 | +$6.5K | |
| 3 | +$5K | |
| 4 |
SIS
Sound Income Strategies
Ft Lauderdale,
Florida
|
+$3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.28K |
Top Sellers
| 1 | -$132K | |
| 2 | -$19.1K | |
| 3 | -$18.8K | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$18K |
| 5 |
GWM
Greenwich Wealth Management
Greenwich,
Connecticut
|
-$15K |